<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01143311</url>
  </required_header>
  <id_info>
    <org_study_id>09-PP-05</org_study_id>
    <nct_id>NCT01143311</nct_id>
  </id_info>
  <brief_title>Role of microRNA in the Development of Cutaneous Squamous Cell Carcinoma</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Nice</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Nice</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to analyze the differential expression of the miR transcriptome in&#xD;
      the distinctive stages of the development of cutaneous squamous cell carcinoma (C-SCC). In&#xD;
      this aim the investigators plan to recruit a cohort of 20 patients suffering of C-SCC and to&#xD;
      collect from each of them, biopsies corresponding to i) non UV-exposed areas ii) UV-exposed&#xD;
      areas, iii) actinic keratosis and iv) tumoral regions. Total RNAs will be prepared from each&#xD;
      biopsy and the miRNA profiles will be characterized using a dedicated miR array.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <start_date>June 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">June 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>miRNAs</measure>
    <time_frame>1 year</time_frame>
    <description>We will select the miRNAs differently expressed between biopsies obtained respectively from areas of normal, pretumoral and tumoral areas (candidate miRs = miRs potentially involved in tumor transformation of epidermal keratinocytes). This will be assessed by analyzing in each of the biopsies from each patient, the expression of different miRs that are known to date, using a dedicated microarray, then by checking the data obtained by quantitative PCR.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Cancer of the Skin</condition>
  <arm_group>
    <arm_group_label>ARM A</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>4 distinct biopsies will be taken&#xD;
in a non UV-exposed area (inner arm)&#xD;
in a UV-exposed area (external surface of the forearm)&#xD;
in a pretumoral region (actinic keratosis)&#xD;
inside the tumor</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Arm A</intervention_name>
    <description>4 distinct biopsies will be taken&#xD;
in a non UV-exposed area (inner arm)&#xD;
in a UV-exposed area (external surface of the forearm)&#xD;
in a pretumoral region (actinic keratosis)&#xD;
inside the tumor</description>
    <arm_group_label>ARM A</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patient older than 40th, suffering of a C-SCC&#xD;
&#xD;
          -  letter of consent signed by the patient&#xD;
&#xD;
          -  to be registered to social security&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pregnant women or breastfeeding.&#xD;
&#xD;
          -  Small C-SCC (size &lt; 6mm)&#xD;
&#xD;
          -  Allergy to Xylocaine&#xD;
&#xD;
          -  All vulnerable (minor, adult guardianship…)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Thierry Passeron, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHU de Nice - Service de Dermatologie - Hôpital de l'Archet - 151 Route de saint-antoine de ginestière 06200 Nice</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHU de Nice - 4 avenue Reine Victoria - Hôpital de Cimiez</name>
      <address>
        <city>Nice</city>
        <state>Alpes-Maritimes</state>
        <zip>06001</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <study_first_submitted>April 19, 2010</study_first_submitted>
  <study_first_submitted_qc>June 11, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 14, 2010</study_first_posted>
  <last_update_submitted>May 31, 2011</last_update_submitted>
  <last_update_submitted_qc>May 31, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 1, 2011</last_update_posted>
  <responsible_party>
    <name_title>CAILLON Cynthia</name_title>
    <organization>DRCI du CHU de Nice</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

